Dexetimide

DB08997ApprovedWithdrawnSmall molecule

A muscarinic antagonist that has been used to treat neuroleptic-induced parkinsonism. Benzetimide is the (-)-enantimorph of dexetimide.

Mechanism: Pharmacologically active on Muscarinic acetylcholine receptor M1, Muscarinic acetylcholine receptor M2, and Muscarinic acetylcholine receptor
Curator reviewed
Formula / weight: C₂₃H₂₆N₂O₂ · 362.4647 g/mol (avg)

Resolves to

Compound

Clinical / RWD

Structure

InChIKeyLQQIVYSCPWCSSD-HSZRJFAPSA-NSMILESO=C1CC[C@@](C2CCN(CC3=CC=CC=C3)CC2)(C(=O)N1)C1=CC=CC=C1

Targets

What you can answer from here — as of August 30, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

553Drug interactionsStructured to mechanism, not free text

1Marketed productAcross 1 country and 1 labeller

1ATC codeIncluding every combination product, plus 15 drug categories

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with Dexetimide, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.